{"efta_number": "EFTA02019581", "page_count": 2, "url": "https://epstein-data.com/EFTA02019581", "pdf_url": "https://epstein-data.com/pdf/EFTA02019581.pdf", "pages": [{"efta_number": "EFTA02019581", "page_number": 0, "text_content": "Early Detection of Ovarian Cancer Receives Essential Support from Science Investor, Jeffrey Epstein.\nThe Ovarian Cancer Research Fund (OCRF), the largest independent organization of its kind in the United\nStates to sponsor ovarian cancer research, has just received significant funding from The Jeffrey Epstein\nVI Foundation to further early detection research.\nEarly detection research of ovarian cancer is critical since ovarian cancer is the most lethal gynecologic\ndisease and yet little is known about how the cancer initiates and metastasizes. In fact, only 20% of\ncases are caught before metastasis to the pelvic area and bloodstream. And once metastasis sets in, less\nthan 50% of women survive the disease beyond five years. Stage One or pre-metastasis ovarian cancer\non the other hand, has a 92% year survival rate beyond five years.\nSince 1998, OCRF has helped fund 62 leading medical centers, provided 164 grants and investments of\napproximately $40 million. The OCRF also focuses on providing funds directly to specific research\nprojects versus funding a general department. Founded in 2000, by science activist, Jeffrey Epstein, The\nJeffrey Epstein VI Foundation sponsors cutting edge science research around the world. A longtime\nsupporter of cancer research, the Foundation also focuses on independent organizations and research\ninitiatives.\nOne of the most revealing early detection projects funded by the OCRF and The Jeffrey Epstein VI\nFoundation is the assertion that high grade serous ovarian cancer, the deadliest type of ovarian cancer\n(causing 70% of ovarian cancer deaths), originates in the fallopian tubes. The study, headed by Martin\nMatzik at Baylor College of Medicine, induced mice with ovarian cancer by removing two gene types:\nthe Dicer, an essential gene for microRNA synthesis and the Pten, a key negative regulator of the P13K\npathway. After full metastasis in these mice, the fallopian tubes from one group of mice were removed\nand left in in the other test group. The results, published in Proceedings of the National Academy of\nSciences, showed that the mice with the fallopian tubes intact continued to develop aggressive\nmetastasis, while the mice with removed fallopian tubes, experienced a dramatic reduction of cancer\nformation.\nToday, ovarian cancer is the fifth leading cause of cancer death among American women. The American\nCancer Society estimates that in 2012, 22,280 women will be diagnosed with ovarian cancer in the\nUnites States and about 15,500 women will die from the disease. Every year, more than 200,000 women\nEFTA_R1_00524324\nEFTA02019581\n", "char_count": 2600}, {"efta_number": "EFTA02019581", "page_number": 1, "text_content": "around the world die from ovarian cancer. These new advances in early detection will soon go to clinical\ntrial and will hopefully reduce the terrible statistics that women face around the world.\nEFTA_R1_00524325\nEFTA02019582\n", "char_count": 225}]}